
ImmuneOncia Therapeutics, Inc. — Investor Relations & Filings
ImmuneOncia Therapeutics, Inc. is a biopharmaceutical company specializing in the development of innovative immuno-oncology therapeutics. Established in 2016 as a joint venture between Yuhan Corporation and Sorrento Therapeutics, the company focuses on creating novel antibody-based drugs for cancer treatment. Its core strategy involves leveraging the immune system to precisely target and attack cancer cells while minimizing damage to healthy tissue. A key candidate in its clinical pipeline is IMC-002, a fully human anti-CD47 monoclonal antibody under development for various malignancies. ImmuneOncia actively engages in strategic partnerships to accelerate its drug development programs, aiming to provide new therapeutic options for cancer patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-27 | Korean | |
| 증권발행실적보고서 | 2026-05-21 | Korean | |
| 증권발행결과(자율공시) | 2026-05-21 | Welsh | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| [기재정정]분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 유상증자또는주식관련사채등의청약결과(자율공시) | 2026-05-15 | Korean |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47253443 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-27 | Korean | ||
| 46721452 | 증권발행실적보고서 | 2026-05-21 | Korean | ||
| 46720046 | 증권발행결과(자율공시) | 2026-05-21 | Welsh | ||
| 46367502 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 46356687 | [기재정정]분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 46349677 | 유상증자또는주식관련사채등의청약결과(자율공시) | 2026-05-15 | Korean | ||
| 44913244 | [발행조건확정]증권신고서(지분증권) | 2026-05-11 | Korean | ||
| 44913075 | [기재정정]투자설명서 | 2026-05-11 | Korean | ||
| 44899598 | [기재정정]주요사항보고서(유상증자결정) | 2026-05-11 | Korean | ||
| 44166438 | 유상증자최종발행가액확정 | 2026-05-08 | Korean | ||
| 39057694 | 주식등의대량보유상황보고서(일반) | 2026-04-30 | Korean | ||
| 39057175 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 35157795 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-22 | Korean | ||
| 33154678 | [발행조건확정]증권신고서(지분증권) | 2026-04-02 | Korean | ||
| 33154645 | 투자설명서 | 2026-04-02 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ImmuneOncia Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17670/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17670 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17670 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17670 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17670}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ImmuneOncia Therapeutics, Inc. (id: 17670)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.